Temperature-controlled RF Ablation is a technology that uses the instrument to output radio frequency energy to reach the lesion site, dehydrate and necrotic cells in the lesion site, and achieve the purpose of cure.
This report contains market size and forecasts of Temperature-Controlled RF Ablation Technology in Global, including the following market information:
Global Temperature-Controlled RF Ablation Technology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Temperature-Controlled RF Ablation Technology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Ultrasound Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Temperature-Controlled RF Ablation Technology include Medtronic, Biosense Webster (Johnson＆Johnson), Abbott, Boston Scientific Corporation, CONMED Corporation, AngioDynamics, AtriCure, Smith+Nephew and Olympus Corporation and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Temperature-Controlled RF Ablation Technology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Temperature-Controlled RF Ablation Technology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Temperature-Controlled RF Ablation Technology Market Segment Percentages, by Type, 2021 (%)
Ultrasound
Laser
Electrical
Cryotherapy
Microwave
Hydrothermal
Global Temperature-Controlled RF Ablation Technology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Temperature-Controlled RF Ablation Technology Market Segment Percentages, by Application, 2021 (%)
Cardiovascular
Cancer
Pain
Orthopedics
Others
Global Temperature-Controlled RF Ablation Technology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Temperature-Controlled RF Ablation Technology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Temperature-Controlled RF Ablation Technology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Temperature-Controlled RF Ablation Technology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Biosense Webster (Johnson＆Johnson)
Abbott
Boston Scientific Corporation
CONMED Corporation
AngioDynamics
AtriCure
Smith+Nephew
Olympus Corporation
BTG plc